SUN — Surgical Innovations Income Statement
0.000.00%
Last trade - 00:00- £4.66m
- £5.11m
- £12.01m
- 21
- 75
- 17
- 28
Annual income statement for Surgical Innovations, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 10.7 | 6.33 | 9.13 | 11.3 | 12 |
| Cost of Revenue | |||||
| Gross Profit | 4.33 | 1.27 | 3.13 | 3.92 | 3.45 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13.2 | 9.5 | 9.58 | 11.3 | 12.6 |
| Operating Profit | -2.44 | -3.17 | -0.455 | 0.041 | -0.596 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.6 | -3.31 | -0.585 | -0.057 | -0.728 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.62 | -3.28 | -0.456 | 0.264 | -0.509 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.62 | -3.28 | -0.456 | 0.264 | -0.509 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.62 | -3.28 | -0.456 | 0.264 | -0.509 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.003 | -0 | 0 | -0.001 |